Søgeresultater - Jong‐Mu Sun
- Showing 1 - 20 results of 72
- Go to Next Page
-
1
Significance of Thymidylate Synthase and Thyroid Transcription Factor 1 Expression in Patients with Nonsquamous Non-small Cell Lung Cancer Treated with Pemetrexed-Based Chemotherap... af Jong‐Mu Sun, Joungho Han, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn
Udgivet 2011Artigo -
2
-
3
-
4
Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either... af Sung Hee Lim, Ji Yun Lee, Jong‐Mu Sun, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn
Udgivet 2014Artigo -
5
-
6
-
7
-
8
-
9
Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Nonsquamous Non–Small-Cell Lung Cancer: A Biomarker-Stratified Randomize... af Jong‐Mu Sun, Jin Seok Ahn, Sin‐Ho Jung, Jiyu Sun, Sang Yun Ha, Joungho Han, Keunchil Park, Myung‐Ju Ahn
Udgivet 2015Artigo -
10
-
11
EGFR Mutation Testing in Patients with Advanced Non-Small Cell Lung Cancer: A Comprehensive Evaluation of Real-World Practice in an East Asian Tertiary Hospital af Yoon‐La Choi, Jong-Mu Sun, Juhee Cho, Sanjay Rampal, Joungho Han, Bhash Parasuraman, Eliseo Güallar, Genehee Lee, Jeeyun Lee, Young Mog Shim
Udgivet 2013Artigo -
12
-
13
-
14
-
15
-
16
Genomic landscape of acquired resistance to third‐generation <i>EGFR</i> tyrosine kinase inhibitors in <i>EGFR</i> T790M‐mutant non–small cell lung cancer af Jiyun Lee, Hong Sook Kim, Boram Lee, Hee Kyung Kim, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Se‐Hoon Lee
Udgivet 2020Artigo -
17
-
18
-
19
-
20
Søgeredskaber:
Relaterede emner
Medicine
Internal medicine
Oncology
Cancer
Lung cancer
Cancer research
Biology
Chemotherapy
Immunotherapy
Genetics
Gene
Pathology
Epidermal growth factor receptor
Surgery
Gastroenterology
Biochemistry
Confidence interval
Gefitinib
Adenocarcinoma
Adverse effect
Immunology
Mutation
Clinical endpoint
Hazard ratio
Immune system
Cisplatin
Erlotinib
Lung
Pembrolizumab
Phases of clinical research